Share This Author
Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction.
It is concluded that neither encainide nor flecainide should be used in the treatment of patients with asymptomatic or minimally symptomatic ventricular arrhythmia after myocardial infarction, even though these drugs may be effective initially in suppressing ventricular arrhythmia.
Effect of the antiarrhythmic agent moricizine on survival after myocardial infarction.
The use of moricizine in CAST-II to suppress asymptomatic or mildly symptomatic ventricular premature depolarizations to try to reduce mortality after myocardial infarction is not only ineffective but also harmful.
Effects of low dose transdermal scopolamine on heart rate variability in acute myocardial infarction.
Asymptomatic Cardiac Ischemia Pilot study (ACIP)
Long-term lead and mortality following pacemaker and defibrillator implantation in adult congenital heart disease
This study aims to compare the effects of system location, surgical history, patient demographics and congenital disease complexity on lead survival, complication distributions and patient mortality in ACHD CIED patients.
SVEP1 is a new regulator of arterial tone
A novel role for SVEP1 and integrin α9β1 is revealed in reducing vascular hyper-contractility in response to a range of vasoconstrictor agonists through an L-type voltage gated Ca2+ channel-mediated effect.
Evaluation of Myocardial Perfusion and Immune Cell Response in Cardiac Allograft Dysfunction of Heart-Transplant Patients
NGD shows decreased stress myocardial perfusion by cardiac MRI and a trend towards increased activated T cells in PBMCs, suggestive of an immune-mediated cause for allograft dysfunction.
P1450Deep vein thrombosis after right sided catheter ablation; more common then previously thought?
It is suggested that DVT may occur at a high frequency then previously thought in this cohort and supports the consideration of peri-procedural prophylactic anticoagulation.